Florida Cancer Specialists - Panhandle

Summary

Florida Cancer Specialists - Panhandle is a medical facility located in Tallahassee, Florida. This center is recognized for care of Lung Cancer, Breast Cancer, Non-Small Cell Lung Cancer, Cancer, Solid Tumors and other specialties. Florida Cancer Specialists - Panhandle is involved with conducting 44 clinical trials across 57 conditions. There are 6 research doctors associated with this hospital, such as Viralkumar Bhanderi, Pareshkumar Patel, MD, Augusto Villegas, and Margarett Ellison.

Top PIs

Clinical Trials running at Florida Cancer Specialists - Panhandle

Breast Cancer

Follicular Lymphoma

Bladder Cancer

Glioblastoma

Brain Tumor

Kidney Cancer

Thyroid Cancer

Pancreatic Cancer

Colon Cancer

Lung Cancer

Giredestrant vs. Fulvestrant

for Advanced Breast Cancer

This trial is testing two drug combinations to treat a specific type of advanced breast cancer that no longer responds to standard hormone treatments. The goal is to see which combination works better by stopping the cancer cells from growing.

Recruiting

2 awards

Phase 3

8 criteria

Disitamab Vedotin

for Breast Cancer

The purpose of this clinical study is to learn about the safety and effects of the study medicine (called disitamab vedotin) for the possible treatment of people with breast cancer that is hard to treat and has spread in the body (advanced cancer). This study is seeking participants who: * have breast cancer that is hard to treat and has spread in the body (advanced cancer) * have tumors that have HER2 on them * have received previous treatment for their advanced breast cancer All participants in this study will receive disitamab vedotin at the study clinic once every 2 weeks as an intravenous (IV) infusion (given directly into a vein). Participants will take the study medicine until they or their doctor decides to stop. This might be because their cancer is getting worse, the study medicine is no longer helping, they have bad side effects, or they wish to stop taking the study medicine. During this time, the participants will have study visits every 2 weeks. After the participants have stopped taking the study medicine, they will have follow-up visits about every 6 weeks unless their cancer gets worse. After that, they will have follow-up phone calls about every 12 weeks. The study team will look at the experiences of people receiving the study medicine. This will help the study team decide if the study medicine is safe and effective.

Recruiting

1 award

Phase 1 & 2

4 criteria